REGULATORY
Japan’s 1st Orphan Regenerative Medicine Status Given to Skin-Derived Cell Sheet
The Ministry of Health, Labor and Welfare has designated JACE, a cultured epidermal autograft of Japan Tissue Engineering, as Japan’s first orphan regenerative medicine product.JACE is expected to be used in patients with congenital giant pigmented nevus, with the product,…
To read the full story
Related Article
- Cultured Epidermal Autograft JACE Recommended for Orphan Designation
October 27, 2014
REGULATORY
- 4 Drug Makers Seek Govt Aid to Upgrade Aging Plants: LDP Hearing
August 24, 2026
- 679 Safety Reports Logged for Regenerative Medical Products in 2H FY2025
August 21, 2026
- Japan Panel to Discuss Approval of 6 NMEs, Leqembi SC on Aug. 26
August 20, 2026
- DPP Lawmaker Calls for Inflation Relief in 2027 Off-Year Drug Price Revision
August 19, 2026
- CEA Review Group Wraps Up Technical Debate, Urges More Company Access
August 19, 2026
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…





